Vital-Imi
  • HOME
  • ABOUT
    • PARTNERS
    • WORK PACKAGES
      • Work Package 1
      • Work Package 2
      • Work Package 3
      • Work Package 4
      • Work Package 5
  • PUBLICATIONS
  • UPDATES
  • MENU
    • EVENTS
    • PARTNERS
    • NEWSLETTER
    • CONTACT
    • PRIVACY POLICY
    • LOGIN
  • Search
  • Menu Menu

PUBLICATIONS

All 3 /Publications 3

Exploratory Analasys of the Economically Justifiable Price of an RSV Vaccine for the Elderly in the Netherland and United Kingdom

Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review)

Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council’s advice

Page 2 of 212

Newsletter

Contact

You can contact us by using the contact form here.

Follow us

  • twitter

The VITAL project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806776. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Scroll to top